Home Newsfeeds UPDATE: Kala Pharmaceuticals Q4 Adj. EPS $(6.46) Up From $(33.94) YoY

UPDATE: Kala Pharmaceuticals Q4 Adj. EPS $(6.46) Up From $(33.94) YoY

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(6.46) per share. This is a 80.97 percent increase over losses of $(33.94) per share from the same period last year.

byHappy Mohamed

March 3, 2023

1 minute read

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(6.46) per share. This is a 80.97 percent increase over losses of $(33.94) per share from the same period last year.

REV Group, Inc. Announces Proposed Secondary Offering Of 12M Shares Of Common Stock And Concurrent Share Repurchase

By Benzinga Newsdesk

February 13, 5:40 PM

REV Group, Inc. (NYSE:REVG) announced today the commencement of an underwritten public offering of 12,000,000 shares of common stock by certain selling stockholders. In connection with the offering, the selling

REVG

Movers
News

What’s Going On With MicroCloud Hologram Stock?

By Erica Kollmann

May 14, 11:05 AM

Shares of GameStop, AMC Entertainment and other meme stock names are racing higher on renewed interest from retail investors after Keith Gill, a.k.a Roaring Kitty, posted a meme to his X account Sunday night followed by a series of cryptic posts on Monday. The meme stock rally has extended to other heavily-shorted stocks, including MicroCloud Hologram. According to data from Benzinga Pro, 19.76% of available shares are being short sold.

HOLO